SEC Form 4 · Updated Daily
GMED
— GLOBUS MEDICAL, INC. OwnershipInsider and institutional ownership derived from SEC Form 4 filings. Click any owner to see their holdings across every company they’ve filed on, and how their position has changed over time.
Current Reporting Owners
| Owner | Role | Shares Owned | As Of | Last Activity |
|---|---|---|---|---|
| GOLDMAN SACHS & CO | 10%+ Owner | 7,643,526 | 2012-08-08 | C |
| GOLDMAN SACHS GROUP INC/ | 10%+ Owner | 7,643,526 | 2012-08-08 | C |
| GS Direct, L.L.C. | 10%+ Owner | 7,643,526 | 2012-08-08 | C |
| PRIVATE EQUITY PARTNERS 2004 DIRECT INVESTMENT FUND LP | 10%+ Owner | 7,643,526 | 2012-08-08 | C |
| GOLDMAN SACHS PEP 2004 DIRECT INVESTMENT ADVISORS, L.L.C. | 10%+ Owner | 7,643,526 | 2012-08-08 | C |
| GS PEP 2002 DIRECT INVESTMENT ADVISORS, L.L.C. | 10%+ Owner | 7,643,526 | 2012-08-08 | C |
| GOLDMAN SACHS PRIVATE EQUITY PARTNERS 2004 OFFSHORE HOLDINGS, L.P. | 10%+ Owner | 7,643,526 | 2012-08-08 | C |
| MULTI-STRATEGY HOLDINGS OFFSHORE ADVISORS, INC. | 10%+ Owner | 7,643,526 | 2012-08-08 | C |
| GOLDMAN SACHS PEP 2004 OFFSHORE HOLDINGS ADVISORS, INC. | 10%+ Owner | 7,643,526 | 2012-08-08 | C |
| GOLDMAN SACHS PEP 2004 EMPLOYEE FUNDS GP, L.L.C. | 10%+ Owner | 7,643,526 | 2012-08-08 | C |
| GS PRIVATE EQUITY PARTNERS 2002 - DIRECT INVESTMENT FUND, L.P. | 10%+ Owner | 7,643,526 | 2012-08-08 | C |
| MULTI-STRATEGY HOLDINGS, L.P. | 10%+ Owner | 7,643,526 | 2012-08-08 | C |
| GOLDMAN SACHS PRIVATE EQUITY PARTNERS 2004 EMPLOYEE FUND, L.P. | 10%+ Owner | 7,643,526 | 2012-08-08 | C |
| GOLDMAN SACHS PRIVATE EQUITY PARTNERS 2004, L.P. | 10%+ Owner | 7,643,526 | 2012-08-08 | C |
| GOLDMAN SACHS INVESTMENT PARTNERS GP, LLC | 10%+ Owner | 7,643,526 | 2012-08-08 | C |
| GOLDMAN SACHS INVESTMENT PARTNERS MASTER FUND, L.P. | 10%+ Owner | 7,643,526 | 2012-08-08 | C |
| GOLDMAN SACHS PEP 2004 ADVISORS, L.L.C. | 10%+ Owner | 7,643,526 | 2012-08-08 | C |
| GOLDMAN SACHS PRIVATE EQUITY CONCENTRATED HEALTHCARE OFFSHORE ADVISORS,INC. | 10%+ Owner | 7,643,526 | 2012-08-08 | C |
| GOLDMAN SACHS PRIVATE EQUITY CONCENTRATED HEALTHCARE FUND OFFSHORE HOLDINGS, L.P. | 10%+ Owner | 7,643,526 | 2012-08-08 | C |
| Davidar David D | Director | 507,675 | 2026-07-27 | G |
| Williams Anthony L | Officer | 165,870 | 2019-03-05 | M |
| Demski David M | Director | 144,263 | 2021-04-26 | M |
| Scavilla Daniel T | Director · Officer | 130,000 | 2024-11-21 | M |
| Paul David C | 10%+ Owner · Director · Officer | 60,417 | 2025-12-08 | M |
| WHEELER KURT | 10%+ Owner | 59,364 | 2016-01-06 | M |
| Murphy A Brett | Officer | 49,768 | 2017-11-09 | S |
| LIPTAK ROBERT | 10%+ Owner | 41,159 | 2016-01-06 | M |
| RHOADS ANN D | Director | 40,384 | 2026-06-04 | M |
| TOBIN JAMES R | Director | 30,000 | 2026-09-15 | M |
| BARON RICHARD A | Reporting Owner | 30,000 | 2014-05-02 | M |
| ZARRILLI STEPHEN T | Director | 25,000 | 2026-08-18 | M |
| Wolterman Dan | Director | 24,025 | 2023-09-01 | A |
| Huller Kelly | Officer | 20,000 | 2026-02-25 | M |
| DeFord John A | Director | 15,578 | 2023-09-01 | A |
| Pfeil Keith W | Director · Officer | 14,167 | 2025-01-10 | M |
| Lemaitre Dan | Director | 13,278 | 2024-11-21 | M |
| Norwalk Leslie V | Director | 10,419 | 2026-01-08 | S |
| Schwartz Eric | Officer | 10,000 | 2018-06-25 | M |
| Kline Kyle | Officer | 3,594 | 2026-01-08 | M |
| Payne Steven | Officer | 3,000 | 2018-09-26 | M |
| Douglas Robert Andrew | Director | 2,005 | 2020-08-24 | P |
| Clarus Ventures I, LLC | Reporting Owner | 0 | 2013-09-03 | J |
| Clarus Lifesciences I, L.P. | 10%+ Owner | 0 | 2013-09-03 | J |
| Clarus Ventures I Management, L.P. | Reporting Owner | 0 | 2013-09-03 | J |
| Simon Nicholas | Reporting Owner | 0 | 2013-09-03 | J |
| STEINMETZ MICHAEL | 10%+ Owner | 0 | 2013-09-03 | J |
| HENNER DENNIS | 10%+ Owner · Director | 0 | 2013-09-03 | J |
| GALAKATOS NICHOLAS | 10%+ Owner | 0 | 2013-09-03 | J |
Recent Filings
| Date | Owner | Activity | Shares | Price | Owned After |
|---|---|---|---|---|---|
| 2026-09-15 | TOBIN JAMES R | Option exercise (derivative) | 15,000 | $0.00 | 0 |
| 2026-09-15 | TOBIN JAMES R | Open-market sale | 30,000 | $74.58 | 0 |
| 2026-09-15 | TOBIN JAMES R | Option exercise | 15,000 | $63.68 | 30,000 |
| 2026-09-15 | TOBIN JAMES R | Option exercise | 15,000 | $53.75 | 15,000 |
| 2026-08-18 | ZARRILLI STEPHEN T | Option exercise (derivative) | 25,000 | $0.00 | 0 |
| 2026-08-18 | ZARRILLI STEPHEN T | Open-market sale | 25,000 | $87.04 | 0 |
| 2026-08-18 | ZARRILLI STEPHEN T | Option exercise | 25,000 | $53.27 | 25,000 |
| 2026-07-27 | Davidar David D | Gift | 2,500 | $0.00 | 507,675 |
| 2026-06-05 | Davidar David D | Option exercise (derivative) | 25,000 | $0.00 | 0 |
| 2026-06-05 | Davidar David D | Open-market sale | 25,000 | $80.76 | 510,175 |
| 2026-06-05 | Davidar David D | Option exercise | 25,000 | $26.27 | 535,175 |
| 2026-06-04 | RHOADS ANN D | Option exercise (derivative) | 25,000 | $0.00 | 0 |
| 2026-06-04 | RHOADS ANN D | Option exercise | 25,000 | $26.27 | 40,384 |
| 2026-02-25 | Huller Kelly | Option exercise (derivative) | 20,000 | $0.00 | 20,000 |
| 2026-02-25 | Huller Kelly | Open-market sale | 20,000 | $94.50 | 0 |
| 2026-02-25 | Huller Kelly | Option exercise | 20,000 | $43.58 | 20,000 |
| 2026-02-12 | Huller Kelly | Option exercise (derivative) | 10,000 | $0.00 | 0 |
| 2026-02-12 | Huller Kelly | Open-market sale | 10,000 | $87.67 | 0 |
| 2026-02-12 | Huller Kelly | Option exercise | 10,000 | $45.64 | 10,000 |
| 2026-01-21 | Huller Kelly | Grant / award (derivative) | 40,000 | $0.00 | 40,000 |
| 2026-01-21 | Davidar David D | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2026-01-21 | Wolterman Dan | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2026-01-21 | DeFord John A | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2026-01-21 | ZARRILLI STEPHEN T | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2026-01-21 | TOBIN JAMES R | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2026-01-21 | RHOADS ANN D | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2026-01-21 | Lemaitre Dan | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2026-01-21 | Douglas Robert Andrew | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2026-01-21 | Paul David C | Grant / award (derivative) | 100,000 | $0.00 | 100,000 |
| 2026-01-21 | Kline Kyle | Grant / award (derivative) | 30,000 | $0.00 | 30,000 |
| 2026-01-21 | Pfeil Keith W | Grant / award (derivative) | 100,000 | $0.00 | 100,000 |
| 2026-01-21 | Norwalk Leslie V | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2026-01-08 | Norwalk Leslie V | Open-market sale | 2,000 | $101.10 | 10,419 |
| 2026-01-08 | Kline Kyle | Option exercise (derivative) | 3,594 | $0.00 | 3,906 |
| 2026-01-08 | Kline Kyle | Open-market sale | 3,594 | $101.10 | 0 |
| 2026-01-08 | Kline Kyle | Option exercise | 3,594 | $51.87 | 3,594 |
| 2025-12-12 | Norwalk Leslie V | Open-market sale | 4,000 | $88.85 | 12,419 |
| 2025-12-08 | Paul David C | Option exercise (derivative) | 34,375 | $0.00 | 0 |
| 2025-12-08 | Paul David C | Option exercise | 34,375 | $25.52 | 60,417 |
| 2025-12-01 | Kline Kyle | Option exercise (derivative) | 5,000 | $0.00 | 0 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.